- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 6th, 2005
One of the latest, most promising treatments for some women with metastatic breast cancer is a new drug that increases the response rate of tumors and causes fewer side effects, researchers say.
The technology behind the drug, nanoparticle albumin-bound paclitaxel (nab-paclitaxel or AbraxaneTM) marks a breakthrough, say Vicente Valero M.D., and Edgardo Rivera, M.D., both in the Department of Breast Medical Oncology at M. D. Anderson.
|Related News Press|
Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016
Curbing the life-long effects of traumatic brain injury August 19th, 2016
New flexible material can make any window 'smart' August 23rd, 2016
University of Puerto Rico and NASA back in the news – XEI reports August 23rd, 2016